Integrated multi-omics unravels solanesol’s multi-organ protection mechanisms against insulin resistance in type 2 diabetic mice

Solanesol demonstrates multi-organ protective effects through gut microbiota-metabolite crosstalk and hepatic lipid/redox homeostasis regulation. Its multi-target efficacy and oral bioavailability position it as a novel, clinically translatable candidate for T2DM management.